期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰腺癌诊治的现状与展望 被引量：2

原文传递
导出
摘要 目前，手术仍然是胰腺癌的首要治疗手段，然而在确诊时80％以上的胰腺癌已进入中晚期，能手术切除的患者只有15％左右。因此，胰腺癌的术前诊断与分期对于采取正确的治疗方案非常重要。我们参照2008年版和2009年版美国国家综合癌症网（NCCN）胰腺癌临床指南，结合我国的实际情况，就胰腺癌的诊治现状与进展分析如下。
作者 赵平 田艳涛
机构地区 中国医学科学院北京协和医学院肿瘤医院腹部外科
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2010年第3期161-163,共3页 Chinese Journal of Oncology
关键词 胰腺肿瘤 诊断 治疗 Pancreatic neoplasms Diagnosis Therapy
分类号 R735.9 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1田艳涛,王成锋,单毅,赵东兵,王贵齐,赵心明,欧阳汉,郝玉芝,孙跃民,曲辉,赵平.不同影像学方法对胰腺癌T、N、M分期及可切除性的评估[J].中华医学杂志,2008,88(40):2829-2832. 被引量：19
  • 2Varadarajulu S,Wallace MB.Applications ofendoscopic ultrasonogralhu in pancreatic cancer.Cancer Control,2004,11:15-22.
  • 3Santo E.Pancreatic cancerr imaging:which method?JOP,2004.5:253-257.
  • 4Taylor AM,Roberts SA,Manson JM.Experience with laparoscopic ultrasonography for defining tumour resectability in carcinoma of the pancreatic head and periampuihry region.Br J Surg,2001,88.1077-1083.
  • 5Cubilla AL,Fortner J,Fitzgerald PJ.Lymph node involvement in carcinoma of the head of the pancreas area.Cancer,1978,41:880-887.
  • 6Nagai H,Kureda A,Morioka Y.Lymphatic and local spread of T1 and T2 pancreatic cancer:a study of autopsy material.Ann Surg,1986,204:65-71.
  • 7Ishikawa O,Ohhigashi H,Sasaki Y,et al.Practical usefulness of lymphatic and connectivetissue clearance for the carcinoma of the pancreas head.Ann Surg,1988,208:215-220.
  • 8Manabe T,Ohshio G,Baba N,et al.Radical pancreatectomy for ductal cell carcinoma of the head of the pstrlcreas.Cancer,1989,64:1132-1137.
  • 9Geer RJ,Brennan MF.Prognostic indicators for survival after resection of pancreatic adenocarcinoma.Am J Surg,1993.165:68-72.
  • 10Henne-Brans D,Vogel I,Lüttges J,et al.Surgery for duetal adenocareinoma of the pancreatic head:staging,complications,and survival after regional versus extended lymphadenectomy.World J Stag,2000,24:595-601.

二级参考文献17

  • 1赵平,王成锋.胰腺肿块组织细胞学诊断的可行性和必要性[J].中华医学杂志,2006,86(14):937-938. 被引量：16
  • 2鲁志诚,郭剑民,张云利,田培林,张林,俞江平,包晓燕.超声内镜对胰腺及壶腹癌术前分期及可切除性的评估[J].中华肿瘤杂志,2006,28(6):441-444. 被引量：5
  • 3Balcom JH,Ratmer DW, Warshaw AL,et al. Ten-year experience with 733 pancreatic resections-changing indications , older patients and decreasing length of hospitalization. Arch Surg, 2001,136: 391-398.
  • 4Trede M, Richter A, Wendl K. Personal observations,opinions and approaches to cancer of the pancreas and periampullaryarea. Surg Clin North Am,2001,81: 595-610.
  • 5Yeo CJ, Cameron JL, Lilemoe KD, et al. Pancreaticoduodenectomy with or without distal gastreetomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcino ma, part 2-randomized controlled trial evaluating survival, morbidity and mortality. Ann Sury,2002,236 : 355-368.
  • 6Ho VV, Heslin M. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg. 2003,237:509 514.
  • 7Fong YM,Gonen M.Rubin D,et al. Long-term survival is superior Mter resection for cancer in high-volume centers. Ann Surg,2005,242: 540-547.
  • 8Heek NT,Duhlman KF,Scholten RJ, et al. Hospital volume and mortality after pancreatic resection: a sysematic review and an evaluation of intervention in the Netherlands. Ann Surg,2005,242:781-790.
  • 9Cameron JL,Riall TS,Coleman JA.et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg, 2006, 244: 10-15.
  • 10Kinoshita H, Hashimoto M, Hashino K, et al. Evaluation of simultaneous excision of pancreatic cancer and the surrounding blood vessels. Kurume Med J,2001,48: 21-24.

共引文献24

同被引文献38

  • 1王丽,杨功焕,李辉,陆星华.1991-2000年中国胰腺癌病死率的变迁[J].中华内科杂志,2005,44(7):509-513. 被引量：39
  • 2Ouyang H, Wang P, Meng Z, et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine]J]. Pancreas, 2011, 40( 1) : 120-125.
  • 3Paulson AS, Tran Cao HS, Tempero MA, et al. Therapeutic advances in pancreatic cancer[J]. Gastroenterology, 2013,144(6) :1316- 1326.
  • 4Levi Z, KarkJD, Afek A, et al. Measured body mass index in adolescence and the incidence of pancreatic cancer in a cohort of 720,000Jewish men[J]. Cancer Causes Control, 2012, 23 ( 2) : 371-378.
  • 5Bracci PM. Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms[J]. Mol Carcinog, 2012, 51 (1) :53-63.
  • 6Li D, MorrisJ5, LiuJ, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer] n.JAMA, 2009, 301 (24) : 2553-2562.
  • 7Fujioka 5, Misawa T, Okamoto T, et al. Predictors for postoperative liver metastasis in patients with resectable pancreatic cancer]J J. Int Surg , 2008, 93(6) :324-330.
  • 8Matsumoto G, Muta M, Tsuruta K, et al. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer[J]. Pancreatology, 2007, 7(2-3) : 167-173.
  • 9Tani M, Kawai M, Miyazawa M, et al. Liver metastasis as an initial recurrence has no impact on the survival of patients witb resectable pancreatic adenocarcinoma[J]. Langenbecks Arch Surg, 2009, 394(2) :249-253.
  • 10FolkmanJ ITole of angiogenesis in tumor growth and metastasis[J]. Semin Oncol, 2002, 29(6 Suppl16) :15-18.

引证文献2

二级引证文献8

中华肿瘤杂志
2010年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
关于我们 | 版权声明 | 联系我们 | 帮助中心| 意见反馈
主办单位：上海市教育委员会
技术支持：重庆维普资讯有限公司
渝公网安备 50019002500403号
使用帮助 返回顶部